Interestingly, the concentration of FABP5, but not that of FABP4, has been reported to be negatively and independently associated with cholesterol efflux capacity from macrophages as a function of HDL cholesterol, suggesting a potential residual risk biomarker in atherosclerosis (32). Here, FABP4 is linked to atherosclerosis.